Clinical Trial

Clinical Study of Nanocrystalline Megestrol in Malnourished Patients With First-Line Non-Small Cell Lung Cancer

Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This prospective interventional clinical study evaluates the efficacy of nanocrystalline megestrol combined with standard care in improving appetite and weight compared to standard care alone in first-line treatment of NSCLC.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-02-11.
Trial Details
NCT Number NCT06828757
Lead Sponsor Hunan Province Tumor Hospital
Conditions Non Small Cell Lung Cancer
Enrollment 94 participants
Start Date 2025-05-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-04-30 (estimated)
Updated on ClinicalTrials.gov 2025-02-19